We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics

News   Jul 05, 2013

 
ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics
 
 
 

RELATED ARTICLES

Fab Secrets of Antibody Binding Revealed

News

Using high-speed atomic force microscopy and hydrogen-deuterium exchange mass spectrometry, scientists showed that the traditional view of antibody binding is not quite right.

READ MORE

Gene Therapy for Niemann-Pick Type a Diseases Moves Forward

News

Research shows that gene replacement therapy for Niemann-Pick type A disease is safe for use in nonhuman primates and has therapeutic effects in mice.

READ MORE

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE